Applied Genetic Technologies (AGTC) – FDA
-
AGTC (AGTC) Receives Positive Type C Meeting Feedback from the FDA for the Company’s Design and Operating Procedures of its Planned cGMP Manufacturing Facility
-
Applied Genetic Technologies (AGTC) Reports Positive Three-Month Interim Results from Skyline Trial of AGTC-501
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AGTC Stock Lookup